GH Research Statistics
Total Valuation
GH Research has a market cap or net worth of $914.93 million. The enterprise value is $621.63 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GH Research has 62.03 million shares outstanding. The number of shares has increased by 12.52% in one year.
| Current Share Class | 62.03M |
| Shares Outstanding | 62.03M |
| Shares Change (YoY) | +12.52% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 26.78% |
| Owned by Institutions (%) | 36.23% |
| Float | 23.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.14 |
| P/TBV Ratio | 3.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 28.32, with a Debt / Equity ratio of 0.00.
| Current Ratio | 28.32 |
| Quick Ratio | 27.72 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -103.08 |
Financial Efficiency
Return on equity (ROE) is -17.86% and return on invested capital (ROIC) is -14.75%.
| Return on Equity (ROE) | -17.86% |
| Return on Assets (ROA) | -14.18% |
| Return on Invested Capital (ROIC) | -14.75% |
| Return on Capital Employed (ROCE) | -19.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$858,460 |
| Employee Count | 50 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.91% in the last 52 weeks. The beta is 0.98, so GH Research's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +61.91% |
| 50-Day Moving Average | 13.71 |
| 200-Day Moving Average | 12.62 |
| Relative Strength Index (RSI) | 56.87 |
| Average Volume (20 Days) | 436,717 |
Short Selling Information
The latest short interest is 1.69 million, so 2.73% of the outstanding shares have been sold short.
| Short Interest | 1.69M |
| Short Previous Month | 1.75M |
| Short % of Shares Out | 2.73% |
| Short % of Float | 7.25% |
| Short Ratio (days to cover) | 4.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -56.90M |
| Pretax Income | -42.92M |
| Net Income | -42.92M |
| EBITDA | -56.82M |
| EBIT | -56.90M |
| Earnings Per Share (EPS) | -$0.73 |
Full Income Statement Balance Sheet
The company has $288.51 million in cash and $582,000 in debt, giving a net cash position of $293.30 million or $4.73 per share.
| Cash & Cash Equivalents | 288.51M |
| Total Debt | 582,000 |
| Net Cash | 293.30M |
| Net Cash Per Share | $4.73 |
| Equity (Book Value) | 291.40M |
| Book Value Per Share | 4.70 |
| Working Capital | 284.38M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$41.67 million and capital expenditures -$127,000, giving a free cash flow of -$41.80 million.
| Operating Cash Flow | -41.67M |
| Capital Expenditures | -127,000 |
| Free Cash Flow | -41.80M |
| FCF Per Share | -$0.67 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GH Research does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.52% |
| Shareholder Yield | -12.52% |
| Earnings Yield | -4.69% |
| FCF Yield | -4.57% |
Analyst Forecast
The average price target for GH Research is $30.11, which is 104.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.11 |
| Price Target Difference | 104.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 17.72% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |